Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 3 Clinical characteristics of synthetic cannabinoids use disorder cases using addiction severity index (ASI)

From: Synthetic cannabinoids impact on cognitive functions

ASI subscales

SC n (%)

Medical

 Slight problem

13 (43.3%)

 Moderate problem

15 (50%)

 Considerable problem

2 (6.7%)

Employment

 Slight problem

1 (3.3%)

 Moderate problem

14 (46.7%)

 Considerable problem

9 (30%)

 Extreme problem

6 (20%)

Drug

 No problem

9 (30%)

 Slight problem

15 (50%)

 Moderate problem

4 (13.3%)

 Considerable problem

2 (6.7%)

Legal

 Slight problem

24 (80%)

 Moderate problem

6 (20%)

Family

 Moderate problem

6 (20%)

 Considerable problem

20 (66.7%)

 Extreme problem

4 (13.3%)

Psychiatric

 Slight problem

7 (23.3%)

 Moderate problem

5 (16.7%)

 Considerable problem

9 (30%)

 Extreme problem

9 (30%)

  1. SC, synthetic cannabinoids
Back to article page